Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Publications
2011
Medicines pay-for-delay back under the microscope
Transparency of European Medicines Regulation
2010
Increasing Calls Within the EU for New Models of Medical Innovation
EMA Talks the ‘Conflicts of Interest’ Talk, but Will it Walk the Walk?
EU Citizens Get a Voice in Pharmacovigilance
Как распознавать продвижение лекарств и как к нему относиться: Практическое руководство
Comprender la promoción farmacéutica y responder a ella: Una guía práctica
Understanding & Responding to Pharmaceutical Promotion: A Practical Guide
WHO Should Refocus its Efforts on Wider Public Health Threats
Direct Patient Reporting of Adverse Drug Reactions
HAI Europe is Granted Full Membership by the European Medicines Agency
2009
European Medicines’ Policy Where it Belongs
Unbiased medicines’ information: European best practices
Wyzwanie dla niezależnej informacji: dyrektywa w sprawie informowania pacjentów
Rozumienie promocji leków i reagowanie na nia: Praktyczny przewodnik 2009
Understanding and Responding to Pharmaceutical Promotion: A Practical Guide
The Tide is Turning Against Pharmaceutical Ads
Protect Legitimate Trade in Essential Medicines
DG Competition Pharmaceutical Sector Inquiry – Final Report
HAI Requests Government Documents on Generic Medicines Seizures
Release of Generic ARV Medicines by Dutch Customs Authorities
2007
HAI Statutenwijziging (HAI Constitution – Dutch)
HAI Constitution
2006
Fast, Furious, and Flexible
2005